Background: Staphylococcus aureus (S. aureus) can behave both as a harmless commensal and as a pathogen. Its significance in the pathogenesis of chronic rhinosinusitis (CRS) is not yet fully understood. This study aimed to determine serum antibody responses to specific staphylococcal antigens in patients with CRS and healthy controls, and to investigate the correlation between specific antibody response and severity of symptoms.
Introduction
Chronic rhinosinusitis (CRS) is a common disease that affects about 10% of the European population, according to a large questionnaire study by the Global Allergy and Asthma European Network (GA 2 LEN) (1) . Its cause is not known, but studies have suggested the involvement of Staphylococcus aureus (2) (3) (4) . In normal maxillary sinuses, S. aureus is rare and is usually regarded as an insignificant finding, but the bacteria have been reported in more than 25% of patients with CRS (5, 6) . About 20% (range:
12-30%) of the population persistently carries S. aureus in the nares, and approximately 30% (range: 16-70%) of the rest are intermittent carriers (7, 8) . Beyond being a harmless commensal, S.
aureus is able to cause various diseases ranging from mild to severe and even fatal conditions. There is an impact of S. aureus in other chronic inflammatory diseases, such as atopic dermatitis (9, 10) and asthma (11) . It has been proposed that in ulcerative colitis a preexisting CRS may affect the colitis by swallowing of sinusitis derived S. aureus antigens (12) . The bacteria display a wide arsenal of virulence factors that can contribute to the pathogenesis of an infection (13) . Superantigens such as toxic shock syndrome toxin-1 (TSST-1) and enterotoxins have been suggested to play a role in CRS, especially in CRS with nasal polyposis (CRSwNP) (3, 13) .
In this study, we focused on IgG antibodies directed against specific components of S. aureus, such as surface adhesins and secreted toxins, which are of benefit in host defence against staphylococcal infections. Humoral immune deficiency has been shown to be a common condition in patients with medically refractory CRS (14) (15) (16) . The individual antibody profile might be of importance for the clinical course/severity of CRS. A review by Van Belkum et al. concluded that there is a need for further studies of host factors that might be able to mitigate the effects of staphylococcal toxins in disease (17) . The aim of the present study was to use protein microarray technology to evaluate antibody responses to specific staphylococcal antigens, especially towards enterotoxins, in serum from patients with CRS and healthy controls. Another aim was to investigate the correlation between severity of symptoms and the specific antibody response. Given knowledge of anti-staphylococcal IgG antibody responses to S. aureus antigens in CRS patients and healthy controls, it might be possible to identify specific biomarkers that could be useful in future studies of the course of the disease and its treatment.
Materials and methods

Patients and controls
Forty-two patients with CRS and 57 healthy controls were included between 2004 and 2010. Two physicians specializing in otorhinolaryngology (UT and SH) performed all inclusion procedures. All patients had been diagnosed with CRS for more than 1 year (range 1-9 years: median: 3 years) prior to inclusion.
The CRS diagnosis was based on history, clinical examination, and CT scans according to the definitions and guidelines of the position paper on rhinosinusitis (18) 
Sample collection and microbiological analyses
Blood samples were collected from patients and controls, and serum was frozen pending further analysis. Information about growth of S. aureus in nares or maxillary sinus was available from a previous study (5) . Information about age, gender, acetylsalicylic acid (ASA) intolerance, asthma, nasal polyp, and smoking habits was collected. Sampling techniques and handling of specimens have been described previously (5) . In brief, bacterial samples were collected from the nares and maxillary sinuses of the patients, and from the nares of the healthy controls 
Microarray based immunoglobulin analysis
Serum samples were analysed using a protein array comprising 61 different S. aureus specific antigens covalently linked to the array surface. Information about the antigens can be extracted from Kloppot et al. (19) and Selle at al. (20) . The S. aureus specific antigens were immobilized using different concentrations ranging from 0.01-0.5 mg/ml. The protein arrays were read out using an ArrayMate and the data were analyzed using IconoClust software (both by Alere Technologies GmbH, Germany). 
Statistical analysis
The participants' demographic characteristics, symptom scores, and antibody measurements are presented using descriptive statistical methods. Continuous data are summarized as mean ± SD or as median with corresponding interquartile range (IQR)
where suitable, and categorical data are presented as percentages. Differences between groups were tested using Student's t-test or the Mann-Whitney U-test or the Kruskal-Wallis test for continuous data where suitable, and using a c2 test or Fisher's exact test for categorical data. Spearman's correlation coefficient was used to evaluate the relationship between symptom scores and serum IgG levels. Holm-Bonferroni correction was applied to control for false discovery rate in multiple hypothesis tests (21) .
A two-sided p-value < 0.05 was considered statistically signifi- 
Results
Initially 43 patients with CRS and 58 healthy controls were enrolled. Of the controls one was excluded due to an age below 18 years and one patient was excluded due to having titanic dental implants reaching the maxillary sinus. For determining anti-staphylococcal IgG antibody responses to S. aureus antigens, sera were available from 39 of 42 CRS patients and 56 of 57 healthy controls; the remaining four sera were lost during processing. Demographic data are given in Table 1 . Asthma and ASA intolerance were both significantly more frequent in the patient group. There was no information available about previous antibiotic treatment prior to inclusion, but none had antibiotics at the time of inclusion. Three patients had 7 days of oral corticosteroid treatment before surgery and inclusion in study. There were no patients with immunosuppressive disease in either group. Most of the patients had regular ongoing treatment with saline rinsing of the nose combined with nasal corticosteroids.
To study the S. aureus specific adaptive immune response, we focused on IgG antibodies directed toward staphylococcal components exposed to the immune system such as secreted proteins and antigens exposed on the surface of the bacteria, entero- *one serum missing, **two sera missing, ***one serum missing, **** two symptom scores missing 
Discussion
CRS is a significant health problem (22) . The cause of the disease is not fully understood, and it is considered to be multifactorial;
probably the result of a complex interaction between host, environment, and microbes. S. aureus has been suggested to have an influence on the pathogenesis (2) . A large meta-analysis, based on 12 case-control studies and a total of 340 cases and 178 controls, concluded that S. aureus superantigens may be a risk factor for the persistence and severity of CRSwNP (3) . It is known that anti-staphylococcal antibody levels in serum contribute to protection, modification of the course, and reduced risk of complications of staphylococcal infections (23, 24) , but little is known about their role in chronic inflammatory disease. A previous study showed highly elevated antibodies in nasal polyps in CRS compared to uncinate tissue from healthy controls (25) . In another study by the same group, local autoantibodies in CRSwNP were elevated (26) . The understanding of the pathophysiology of CRS involve complex immunology. CRSwNP and CRSsNP seem to have different endotypes, with inflammation mediated as Th2 and Th1 reaction (27, 28) . There is evidence for the involvement of S. aureus in CRSwNP, altering the cytokine response toward a Th2 reaction with eosinophilia, polyclonal local IgE production (2, 29, 30) . In the present study, we focused on IgG to investigate whether patients with CRS had different serum IgG antibody response to specific staphylococcal antigens than healthy controls, and especially toward staphylococcal enterotoxins. We also investigated the correlation between severity of symptoms and specific immune response.
We found statistically significantly higher anti-staphylococcal
IgG levels for LukF-PV and TSST-1 in CRS patients than in controls. In addition, when comparing specific anti-staphylococcal IgG antibody levels in CRS patients with growth of S. aureus in maxillary sinus versus healthy controls, we found statistically significant higher IgG levels toward TSST-1 in the CRS patients.
In a previous study we showed a significantly higher presence of S. aureus in the nares of CRS patients than in controls, as well as a high presence of S. aureus in both maxillary sinus and nares of patients with CRS (5) . The immune system in CRS cases might be more exposed to TSST-1 and LukF-PV than the immune system in controls, resulting in a stronger IgG response. However, the presence of S. aureus in maxillary sinus did not have any impact on the anti-staphylococcal IgG levels in serum from CRS with primary skin infection and necrotizing pneumonia (31) , but its role in chronic diseases such as CRS has not been evaluated.
TSST-1 and staphylococcal enterotoxins act as superantigens.
Van Belkum et al. showed that increased antibody levels exist in individuals persistently colonized with S. aureus (32) . Our study used one-time sampling, and so it was not possible to investigate the effect of persistent colonization. In general, we found higher levels of anti-staphylococcal IgG antibodies in serum from patients with CRS compared to healthy controls, and also in CRS patients with growth of S. aureus in maxillary sinus compared to healthy controls, which could reflect more persistent colonization in patients with CRS or a presence of S.
aureus strains more prone to produce antigens that promote antibody response. However, previous staphylococcal infection could affect the serum level of antibodies. We found highly variable levels of specific anti-staphylococcal IgG antibody levels towards staphylococcal antigens in both healthy individuals and patients with CRS, and as can be seen in the glyph plot ( Figure   2 ), no contexture of immunoglobulin composition was repetitive for these groups. One limitation is that we do not know how specific anti-staphylococcal antibodies varies over time in a normal population. A retrospective study investigating the role of specific antibody deficiency in 129 CRS patients with medically refractory CRS (33) found low baseline anti-pneumococcal antibody levels in 72% of the patients, and of these 11.6%
of these showed an inadequate response to vaccination with (15) . We found generally higher antibody levels toward S. aureus antigens in CRS cases than controls. S. aureus . The raised levels of TSST-1 and LukF-PV antibodies might indicate a relevance of these enterotoxins in the pathogenesis of CRS disease. It is interesting that it is the staphylococcal antigens TSST-1 and PVL, according to the significant antibodies demonstrated in the present study, that the CRS patients actually have been exposed to and display a immune response against.
especially since these exotoxins display superantigenic properties and may induce and maintain chronic inflammation.
Holm-Bonferroni correction for multiple comparison was applied to all data to control for false discovery rate in multiple hypothesis tests, and this strengthens our findings. We used a 6-parameter symptom score for CRS patients and controls to evaluate severity of symptoms correlated to anti-staphylococcal IgG levels. A similar symptom score has been used in a previous study (36) . Not surprisingly, the patients had a significantly higher symptom score than controls. The scoring of symptoms was 
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